Ophthalmic Start-Up Chief Executive Officers' Perceptions of Development Hurdles.
- Published in:
- Ophthalmic Research, 2018, v. 59, n. 2, p. 110, doi. 10.1159/000479376
- By:
- Publication type:
- Article
Works matching IS 00303747 AND DT 2018 AND VI 59 AND IP 2
Results: 8
1
2
Modulation of the Proteasome Pathway by Nano-Curcumin and Curcumin in Retinal Pigment Epithelial Cells.
- Published in:
- Ophthalmic Research, 2018, v. 59, n. 2, p. 98, doi. 10.1159/000481261
- By:
- Publication type:
- Article
3
Multimodal Evaluation of the Fellow Eye of Patients with Retinal Angiomatous Proliferation.
- Published in:
- Ophthalmic Research, 2018, v. 59, n. 2, p. 88, doi. 10.1159/000481262
- By:
- Publication type:
- Article
4
Interocular Symmetry of Choroidal Thickness and Volume in Healthy Eyes on Optical Coherence Tomography.
- Published in:
- Ophthalmic Research, 2018, v. 59, n. 2, p. 81, doi. 10.1159/000481663
- By:
- Publication type:
- Article
5
Optical Coherence Tomography Angiography in Optic Nerve Drusen.
- Published in:
- Ophthalmic Research, 2018, v. 59, n. 2, p. 76, doi. 10.1159/000481889
- By:
- Publication type:
- Article
6
Fluocinolone Acetonide Intravitreal Implant 190 μg (ILUVIEN®) in Vitrectomized versus Nonvitrectomized Eyes for the Treatment of Chronic Diabetic Macular Edema.
- Published in:
- Ophthalmic Research, 2018, v. 59, n. 2, p. 68, doi. 10.1159/000484091
- By:
- Publication type:
- Article
7
Different Phenotypes of Mild Nonproliferative Diabetic Retinopathy with Different Risks for Development of Macular Edema (C-TRACER Study).
- Published in:
- Ophthalmic Research, 2018, v. 59, n. 2, p. 59, doi. 10.1159/000484666
- By:
- Publication type:
- Article
8
Front & Back Matter.
- Published in:
- Ophthalmic Research, 2018, v. 59, n. 2, p. 1, doi. 10.1159/000487497
- Publication type:
- Article